Plunkett Research Online: Neoleukin Therapeutics Inc

NEOLEUKIN THERAPEUTICS INC (NLTX) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Neoleukin Therapeutics Inc operates as a biopharmaceutical company. The firm generates immunotherapies using de novo protein design technology. It uses computational methods to design proteins that demonstrate specific pharmaceutical properties that provide potentially superior therapeutic benefits .....


NEOLEUKIN THERAPEUTICS INC

Ticker: NLTX
Exchange: NAS
Parent Company:
Employees:
Fiscal Year Ends in

Phone: 206 732-2133
Fax: 778 331-4486
Address: 1616 Eastlake Ave. E., Ste. 360
Seattle, WA 98102-3795 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Contacts Description

Donna CochenerCEO/General Counsel/Secretary
Sean SmithCFO/Chief Accounting Officer
See More
Neoleukin Therapeutics Inc operates as a biopharmaceutical company. The firm generates immunotherapies using de novo protein design technology. It uses computational methods to design proteins that demonstrate specific pharmaceutical properties that provide potentially superior therapeutic benefits .....See More See More

$USD, In whole numbers2023202220212020201920182017
Sales
Profits
Brands, Divisions and Affiliates Top Salaries
Salary
Bonus
Other Thoughts Corporate Culture